Human Molecular Genetics, 2003, Vol. 12, No. 8 879-889
DOI: 10.1093/hmg/ddg096
© 2003 Oxford University Press
Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1)
1Laboratoire d'Ingénierie des Protéines et Contrôle Métabolique, Département de Biologie des Génomes, Institut Jacques Monod, Unité Mixte de Recherche 7592 CNRS-Universités Paris 6 and 7, 2 place Jussieu, F-75251 Paris cedex 05, France, 2University of Luebeck, Isotopes Laboratory TNF, Ratzeburger Allee 160, D-23538 Luebeck, Germany and 3Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA
Received December 20, 2002; Accepted February 7, 2003
The YFH1 gene is the yeast homologue of the human FRDA gene, which encodes the frataxin protein. Saccharomyces cerevisiae cells lacking the YFH1 gene showed very low cytochrome content. In
yfh1 strains, the level of ferrochelatase (Hem15p) was very low, as a result of transcriptional repression of HEM15. However, the low amount of Hem15p was not the cause of haeme deficiency in
yfh1 cells. Ferrochelatase, a mitochondrial protein, able to mediate insertion of iron or zinc into the porphyrin precursor, made primarily the zinc protoporphyrin product. Zinc protoporphyrin instead of haeme accumulated during growth of
yfh1 mutant cells and, furthermore, preferential formation of zinc protoporphyrin was observed in real time. The method for these studies involved direct presentation of porphyrin to mitochondria and to ferrochelatase of permeabilized cells with intact architecture, thereby specifically testing the iron delivery portion of the haeme biosynthetic pathway. The studies showed that
yfh1 mutant cells are defective in iron use by ferrochelatase. Mössbauer spectroscopic analysis showed that iron was present as amorphous nano-particles of ferric phosphate in
yfh1 mitochondria, which could explain the unavailability of iron for haeme synthesis. A high frequency of suppressor mutations was observed, and the phenotype of such mutants was characterized by restoration of haeme synthesis in the absence of Yfh1p. Suppressor strains showed a normal cytochrome content, normal respiration, but remained defective in FeS proteins and still accumulated iron into mitochondria although to a lesser extent. Yfh1p and Hem15p were shown to interact in vitro by Biacore studies. Our results suggest that Yfh1 mediates iron use by ferrochelatase.
* To whom correspondence should be addressed. Tel: +33 144276356; Fax: +33 144275716; Email: lesuisse{at}ijm.jussieu.fr
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Hausmann, B. Samans, R. Lill, and U. Muhlenhoff Cellular and Mitochondrial Remodeling upon Defects in Iron-Sulfur Protein Biogenesis J. Biol. Chem., March 28, 2008; 283(13): 8318 - 8330. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Anderson, K. Kirby, W. C. Orr, A. J. Hilliker, and J. P. Phillips Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia PNAS, January 15, 2008; 105(2): 611 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dolezal, A. Dancis, E. Lesuisse, R. Sutak, I. Hrdy, T. M. Embley, and J. Tachezy Frataxin, a Conserved Mitochondrial Protein, in the Hydrogenosome of Trichomonas vaginalis Eukaryot. Cell, August 1, 2007; 6(8): 1431 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shan, E. Napoli, and G. Cortopassi Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones Hum. Mol. Genet., April 15, 2007; 16(8): 929 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Llorens, J. A. Navarro, M. J. Martinez-Sebastian, M. K. Baylies, S. Schneuwly, J. A. Botella, and M. D. Molto Causative role of oxidative stress in a Drosophila model of Friedreich ataxia FASEB J, February 1, 2007; 21(2): 333 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, E. R. Lyver, S. A. B. Knight, D. Pain, E. Lesuisse, and A. Dancis Mrs3p, Mrs4p, and Frataxin Provide Iron for Fe-S Cluster Synthesis in Mitochondria J. Biol. Chem., August 11, 2006; 281(32): 22493 - 22502. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Layer, S. Ollagnier-de Choudens, Y. Sanakis, and M. Fontecave Iron-Sulfur Cluster Biosynthesis: CHARACTERIZATION OF ESCHERICHIA COLI CYaY AS AN IRON DONOR FOR THE ASSEMBLY OF [2Fe-2S] CLUSTERS IN THE SCAFFOLD IscU J. Biol. Chem., June 16, 2006; 281(24): 16256 - 16263. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gakh, S. Park, G. Liu, L. Macomber, J. A. Imlay, G. C. Ferreira, and G. Isaya Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity Hum. Mol. Genet., February 1, 2006; 15(3): 467 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Schoenfeld, E. Napoli, A. Wong, S. Zhan, L. Reutenauer, D. Morin, A. R. Buckpitt, F. Taroni, B. Lonnerdal, M. Ristow, et al. Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells Hum. Mol. Genet., December 15, 2005; 14(24): 3787 - 3799. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Anderson, K. Kirby, A. J. Hilliker, and J. P. Phillips RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila Hum. Mol. Genet., November 15, 2005; 14(22): 3397 - 3405. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gonzalez-Cabo, R. P. Vazquez-Manrique, M. A. Garcia-Gimeno, P. Sanz, and F. Palau Frataxin interacts functionally with mitochondrial electron transport chain proteins Hum. Mol. Genet., August 1, 2005; 14(15): 2091 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, E. R. Lyver, S. A. B. Knight, E. Lesuisse, and A. Dancis Frataxin and Mitochondrial Carrier Proteins, Mrs3p and Mrs4p, Cooperate in Providing Iron for Heme Synthesis J. Biol. Chem., May 20, 2005; 280(20): 19794 - 19807. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Seznec, D. Simon, C. Bouton, L. Reutenauer, A. Hertzog, P. Golik, V. Procaccio, M. Patel, J.-C. Drapier, M. Koenig, et al. Friedreich ataxia: the oxidative stress paradox Hum. Mol. Genet., February 15, 2005; 14(4): 463 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lesuisse, S. A. B. Knight, M. Courel, R. Santos, J.-M. Camadro, and A. Dancis Genome-Wide Screen for Genes With Effects on Distinct Iron Uptake Activities in Saccharomyces cerevisiae Genetics, January 1, 2005; 169(1): 107 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Stehling, H.-P. Elsasser, B. Bruckel, U. Muhlenhoff, and R. Lill Iron-sulfur protein maturation in human cells: evidence for a function of frataxin Hum. Mol. Genet., December 1, 2004; 13(23): 3007 - 3015. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Campanella, G. Isaya, H. A. O'Neill, P. Santambrogio, A. Cozzi, P. Arosio, and S. Levi The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast Hum. Mol. Genet., October 1, 2004; 13(19): 2279 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Bulteau, H. A. O'Neill, M. C. Kennedy, M. Ikeda-Saito, G. Isaya, and L. I. Szweda Frataxin Acts as an Iron Chaperone Protein to Modulate Mitochondrial Aconitase Activity Science, July 9, 2004; 305(5681): 242 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lange, U. Muhlenhoff, M. Denzel, G. Kispal, and R. Lill The Heme Synthesis Defect of Mutants Impaired in Mitochondrial Iron-Sulfur Protein Biogenesis Is Caused by Reversible Inhibition of Ferrochelatase J. Biol. Chem., July 9, 2004; 279(28): 29101 - 29108. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. S. Chen, R. J. Crisp, M. Valachovic, M. Bard, D. R. Winge, and J. Kaplan Transcription of the Yeast Iron Regulon Does Not Respond Directly to Iron but Rather to Iron-Sulfur Cluster Biosynthesis J. Biol. Chem., July 9, 2004; 279(28): 29513 - 29518. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoon and J. A. Cowan Frataxin-mediated Iron Delivery to Ferrochelatase in the Final Step of Heme Biosynthesis J. Biol. Chem., June 18, 2004; 279(25): 25943 - 25946. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. RICHARDSON Novel Chelators for Central Nervous System Disorders That Involve Alterations in the Metabolism of Iron and Other Metal Ions Ann. N.Y. Acad. Sci., March 1, 2004; 1012(1): 326 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shakoury-Elizeh, J. Tiedeman, J. Rashford, T. Ferea, J. Demeter, E. Garcia, R. Rolfes, P. O. Brown, D. Botstein, and C. C. Philpott Transcriptional Remodeling in Response to Iron Deprivation in Saccharomyces cerevisiae Mol. Biol. Cell, March 1, 2004; 15(3): 1233 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Rutherford and A. J. Bird Metal-Responsive Transcription Factors That Regulate Iron, Zinc, and Copper Homeostasis in Eukaryotic Cells Eukaryot. Cell, February 1, 2004; 3(1): 1 - 13. [Full Text] [PDF] |
||||
![]() |
G. Karthikeyan, J. H. Santos, M. A. Graziewicz, W. C. Copeland, G. Isaya, B. V. Houten, and M. A. Resnick Reduction in frataxin causes progressive accumulation of mitochondrial damage Hum. Mol. Genet., December 15, 2003; 12(24): 3331 - 3342. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park, O. Gakh, H. A. O'Neill, A. Mangravita, H. Nichol, G. C. Ferreira, and G. Isaya Yeast Frataxin Sequentially Chaperones and Stores Iron by Coupling Protein Assembly with Iron Oxidation J. Biol. Chem., August 15, 2003; 278(33): 31340 - 31351. [Abstract] [Full Text] [PDF] |
||||








